ArticleOncoTargets and therapy2025

Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?

Qing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.